-
28781
Impaired Expression of Humanin during Adrenocortical Carcinoma
Published 2024-01-01Get full text
Article -
28782
-
28783
Development and validation of the novel subclassification of pN3 for patients with esophageal cancer
Published 2023-05-01Get full text
Article -
28784
Bariatric Surgery during COVID-19 Pandemic from Patients’ Point of View—The Results of a National Survey
Published 2020-06-01Get full text
Article -
28785
Medicaroid robotic assisted surgery system: A feasibility study
Published 2023-05-01Get full text
Article -
28786
First national analysis of severe obesity hospitalizations in Italy: insights from discharge card database
Published 2024-02-01Get full text
Article -
28787
One Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass: A Randomized Prospective Trial
Published 2024-02-01Get full text
Article -
28788
-
28789
-
28790
-
28791
-
28792
-
28793
Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the dis...
Published 2021-05-01“…The diagnosis of primary biliary cholangitis (PBC) was established according to the recommendations of the American Association for the Study of Liver Diseases, the Russian Gastroenterological Association and the Russian Society for the Study of the Liver. …”
Get full text
Article -
28794
Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colo...
Published 2016-11-01“…Atsushi Tsuruta,1,* Kazuki Yamashita,2,* Hiroaki Tanioka,3 Akihito Tsuji,4,5 Michio Inukai,6 Toshiki Yamakawa,7 Tomoki Yamatsuji,8 Masanori Yoshimitsu,9 Kazuhiro Toyota,10 Taketoshi Yamano,11 Takeshi Nagasaka,12 Masazumi Okajima13 On behalf of the Japan Southwest Oncology Group (JSWOG) 1Department of Digestive Surgery, Kawasaki Medical School Hospital, 2Department of Surgery, 3Department of Medical Oncology, Okayama Rosai Hospital, Okayama, 4Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, 5Department of Clinical Oncology, Faculty of Medicine, Kagawa University Hospital, Kagawa, 6Department of Medicine, Okayama Saiseikai General Hospital, Okayama, 7Department of Surgery, Kagawa Prefectural Central Hospital, Takamatsu, 8Department of General Surgery, Kawasaki Medical School, Okayama, 9Department of Surgery, Hiroshima City Asa Hospital, Hiroshima, 10Department of Surgery, National Hospital Organization Higashihirosima Medical Center, Higashihiroshima, 11Department of Surgery, Kurashiki Medical Center, 12Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 13Department of Surgery, Hiroshima City Hospital, Hiroshima, Japan *These authors contributed equally to this work Background: Six months of oxaliplatin-based chemotherapy is the standard adjuvant chemotherapy for completely resected stage III colorectal cancer (CRC). …”
Get full text
Article -
28795
-
28796
-
28797
-
28798
-
28799
-
28800